SlideShare uma empresa Scribd logo
1 de 22
THE EFFECTS OF
GRANULOCYTE
COLONY
STIMULATING
FACTOR ON
STROKE INDUCED
RATS
Matthew Busel

Pine Crest School

Work conducted at Florida Atlantic
University
INTRODUCTION: GCSF
 Granulocyte Colony Stimulating Factor (GCSF) is a growth factor
  and cytokine that stimulates the proliferation and mobilization of
  hematopoietic stem cells
 Its actions are mediated by binding to specific GCSF receptors
  (GCSFRs)
 Although its main clinical use has been to counteract neutropenia,
  recent studies have reported that GCSFRs are located on the
  brain leading to neuroprotective effects of the drug
 By decreasing the rate of neuronal death many central nervous
  system (CNS) disorders may be counteracted against
INTRODUCTION: CEREBRAL ISCHEMIA

 Focal cerebral ischemia (stroke) is a CNS disorder in which the
  cerebral blood vessels are blocked, resulting in an inadequate
  blood flow to the brain and subsequent oxygen (hypoxic) –
  glucose deprived environment
 In this state the brain cannot meet metabolic demands and
  neuronal death will eventually be initiated via apoptosis
 The resulting ischemic infarct (area of dead cell tissue) includes a
  central core (an area of severe ischemia) and a surrounding
  penumbra, which is vulnerable if the cell death is not arrested

                                       White = core

                                       Red = penumbra
INTRODUCTION: APOPTOTIC
PATHWAYS
 The endoplasmic reticulum (ER) is responsible for the proper folding
    and sorting of proteins
   During an ischemic insult the ER becomes stressed and will try to
    restore normal function by deactivating protein translation signaling
    pathways while activating other pathways that increase the
    production of chaperone molecules that facilitates protein folding
   If it is unsuccessful in rectifying its stressed state and restoring
    normal function, the ER will initiate an apoptotic cascade
   Caspase 12 is an ER-membrane associated protein and one of the
    initiators of the caspase-mediated apoptotic pathway
   Glucose regulated protein 78 (GRP78) is a chaperon molecule
    associated with the ER
INTRODUCTION: EXPERIMENT
 The molecular expression of GRP78 and Caspase 12 were
  compared in GCSF treated and untreated rats
 Both GRP78 and Caspase 12 are excellent indicators of cell
  death
HYPOTHESIS
 If the molecular expression of GRP78 and Caspase 12 are
  measured in GCSF treated and untreated rats after focal cerebral
  ischemia, treated rats will have lower expression of the selected
  indicators and therefore lower cell death in both the core and
  penumbra of the brain
METHODS: WESTERN BLOT
 Frozen homogenates/lysates of protein samples (from two rats to
  increase diversity with sample population) were used to perform
  western blot assays
 Briefly, protein homogenates/lysates were boiled for 5 minutes and
  centrifuged
 Each lane was loaded with 50 μg of protein and subjected to sodium
  dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) on
  12% gels and then electrophoretically transferred to nitrocellulose
  membranes
 Once protein transfers were completed, the nitrocellulose
  membranes were blocked in 5% nonfat dry milk in TBST (20 mmol/L
  Tris base, pH 7.6, 137 mmol/L NaCl, and 0.05% Tween 20) for 1 hour
  at room temperature and rinsed in TBS-T (50 mM Tris, 170 mM NaCl,
  0.2% [vol/vol] Tween 20; pH 7.5)
METHODS: WESTERN BLOT
 They were then incubated with primary antibodies (anti-caspase
  12, anti-Grp78 and anti-GAPDH, all at 1:1000 dilution) and
  incubated in TBST and the corresponding primary antibody
  (1:1000) overnight at 4°C
 The membranes were subsequently washed in TBST and
  incubated for 1.5 hours at room temperature with the same
  corresponding secondary antibody in a dilution of 1:3000 with
  TBST
 Immunoreactive bands were visualized in the linear range with
  enhanced chemoluminescence
 Films were scanned and the optical density was determined with
  ImageJ
METHODS: ANALYSIS
 All statistical data shown was expressed as the mean optical
  density for each treatment
 A one-way ANOVA test was used to compare means between
  groups and determine statistical significance
 Differences of P<0.05 were considered statistically significant
RESULTS: CASPASE 12
      This figure shows the mean normalized optical density values
        determined by ImageJ for Caspase 12
      GAPDH was used as the internal control to normalize values



                                                                                        Click to next slide for
                                                                                        more explanation




                                                    Legend
                                        (50 mg protein lysate in each well)
1.    Naïve- non-operated controls
2.    Sham- operated controls not given focal ischemia
3.    MCAO- rats were given focal ischemia by middle cerebral artery occlusion
4.    MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
RESULTS: CASPASE 12
   The data demonstrates a relatively large decrease in expression
      between the MCAO and MCAO+GCSF groups in the core and an
      increase between groups in the penumbra

Caspase 12: 40 kDa
1   2     3    4




                                                     Legend
                                         (50 mg protein lysate in each well)
 1.   Naïve- non-operated controls
 2.   Sham- operated controls not given focal ischemia
 3.   MCAO- rats were given focal ischemia by middle cerebral artery occlusion
 4.   MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
RESULTS: CASPASE 12
  ANOVA Tests were run for the results of both the core and
    penumbra
  Since both had p values > .05, results were determined to be
    statistically insignificant
Core




Penumbra
RESULTS: CASPASE 12
 A T-Test was then run which also proved results to be statistically
  insignificant because the p value > .05
RESULTS: GRP78
      This figure displays the mean normalized optical density values
        determined by ImageJ for GRP78
      GAPDH was used as the internal control to normalize values



                                                                                        Click to next slide for
                                                                                        more explanation




                                                    Legend
                                        (50 mg protein lysate in each well)
1.    Naïve- non-operated controls
2.    Sham- operated controls not given focal ischemia
3.    MCAO- rats were given focal ischemia by middle cerebral artery occlusion
4.    MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
RESULTS: GRP78
    The data demonstrates a decrease in expression between the
       MCAO and MCAO+GCSF groups in the core and an increase in
       the penumbra


GRP78: 72-80 kDa
1 2     3 4




                                                      Legend
                                          (50 mg protein lysate in each well)
  1.   Naïve- non-operated controls
  2.   Sham- operated controls not given focal ischemia
  3.   MCAO- rats were given focal ischemia by middle cerebral artery occlusion
  4.   MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
RESULTS: SUMMARY
 With both Caspase 12 and GRP78, there was a decrease in
  expression in the treated rats in the core, but an increase in
  expression in the treated rats in the penumbra
DISCUSSION: CASPASE 12
RESULTS
 In response to excess calcium in the ER lumen, an apoptotic
  cascade is initiated involving Caspase 12 with the final death
  marker prior to apoptosis being Caspase 3
 Consistent with previous studies, the core GCSF-treated rats
  showed reduced Caspase 12 expression
 The penumbra GCSF-treated rats showed increased Caspase 12
  expression in the penumbra in complete disagreement with
  previous studies
DISCUSSION: GRP78 RESULTS
 In the absence of ER stress, the chaperone protein GRP78
  protects cells from apoptosis by binding to IRE1, PERK, ATF6,
  and Caspase 14
 GRP78 normally inhibits the activation of these intracellular
  cytoplasmic kinases but when the ER is stressed, GRP78
  dissociates from the cytoplasmic molecules to sequester the extra
  calcium
 Similar to the results with Caspase 12, the core-GCSF treated
  groups decreased GRP78 expression, but in the penumbra the
  opposite effect occurred.
DISCUSSION: STATISTICS
 There was no statistical significance between any of the treatment
    groups analyzed
   A possible reason for this result is the relatively small sample size of
    data used in this experiment compared to similar studies
   Also there was a relatively high level of variation within each group,
    which may have contributed to some of the observed discrepancies
    in the data analysis
   Another statistical discrepancy may have come from GAPDH, which
    was used to normalize OD values
   As demonstrated in Figure 1, the expression of GAPDH in the MCAO
    group was significantly smaller than any other group making the
    normalized value of the MCAO group relatively smaller
FUTURE RESEARCH
 In future research, additional Western Blots with Caspase 12 and
  GRP78 would be run in order to compile more data and create
  more reliable results
 As this research only investigated pro-death markers (Caspase
  12) and ER stress indicators (GRP78), it would be interesting to
  assay BCl2, a pro-survival marker in future research
SOURCES
 Http://www.weizmann.ac.il/immunology/Lapidot/documents/5.pdf (2002): n. pag. 17 June 2002.
    Web.
   "Annals of Oncology." G-CSF Prevents the Suppression of Bone Marrow Hematopoiesis
    Induced by IL-12 and Augments Its Antitumor Activity in a Melanoma Model in Mice. N.p., n.d.
    Web. 26 Sept. 2012. <http://annonc.oxfordjournals.org/content/9/1/63.short>.
   "Phenotypic Changes in Neutrophil Granulocytes after G-CSF Administration in Patients with
    Acute Lymphoblastic Leukemia under Chemotherapy." Phenotypic Changes in Neutrophil
    Granulocytes after G-CSF Administration in Patients with Acute Lymphoblastic Leukemia
    under Chemotherapy. N.p., n.d. Web. 26 Sept. 2012.
    <http://www.haematologica.org/content/83/6/573.abstract>.
   "A Role for G-CSF ( Granulocyte-Colony Stimulating Factor ) Review ND ABBREVIATIONS
    SC." Free Reference Manager and PDF Organizer. N.p., n.d. Web. 26 Sept. 2012.
    <http://www.mendeley.com/research/a-role-for-gcsf-granulocytecolony-stimulating-factor-
    review-nd-abbreviations-sc/>.
   Khan, Shaheen N., and Fridoon J. Ahmad. "IGF-1 and G-CSF Complement Each Other in
    BMSC Migration towards Infarcted Myocardium in a Novel in Vitro Model." Cell Biology
    International 33.6 (2009): n. pag. June 2009. Web. <IGF-1 and G-CSF complement each other
    in BMSC migration towards infarcted myocardium in a novel in vitro model>.
   Chopp, M., S. Frinak, D. R. Walton, and M. B. Smith. "Intracellular Acidosis during and after
    Cerebral Ischemia: In Vivo Nuclear Magnetic Resonance Study of Hyperglycemia in Cats."
    N.p., n.d. Web. <http://stroke.ahajournals.org/content/18/5/919.full.pdf>.
SOURCES
   “Neuroprotective Effect of Recombinant Human Granulocyte Colony-stimulating Factor in Transient Focal Ischemia of
    Mice." Nature.com. Nature Publishing Group, n.d. Web. 26 Sept. 2012.
   "Anti-apoptotic Effect of Granulocyte-colony Stimulating Factor after Focal Cerebral Ischemia in the Rat." Neuroscience
    143.4 (2006): 965-74. 28 Dec. 2006. Web. <http://www.sciencedirect.com/science/article/pii/S0306452206012310>.
   Pan, Chunliu, Amit Gupta, Howard Prentice, and Jang-yen Wu. "Protection of Taurine and Granulocyte Colony-
    Stimulating Factor against Excitotoxicity Induced by Glutamate in Primary Cortical Neurons." N.p., 2010. Web.
    <http://www.biomedcentral.com/content/pdf/1423-0127-17-S1-S18.pdf>.
   "Neuroprotective Effect of Granulocyte Colonyâ   Stimulating Factor After Focal Cerebral Ischemia." Neuroprotective
    Effect of Granulocyte Colonyâ   Stimulating Factor After Focal Cerebral Ischemia. N.p., n.d. Web. 26 Sept. 2012.
    <http://stroke.ahajournals.org/content/34/3/745.long>.
   "Anti-apoptotic Effect of Granulocyte-colony Stimulating Factor after Focal Cerebral Ischemia in the Rat." Neuroscience
    143.4 (2006): 965-74. 28 Dec. 2006. Web. <http://www.sciencedirect.com/science/article/pii/S0306452206012310>.
   "Caspase-12 Mediates Endoplasmic-reticulum-specific Apoptosis and Cytotoxicity by Amyloid-beta." National Center for
    Biotechnology Information. U.S. National Library of Medicine, n.d. Web. 26 Sept. 2012.
    <http://www.ncbi.nlm.nih.gov/pubmed/10638761>.
   "Research." School of Biological and Biomedical Sciences Interorganellar Signalling Laboratory. N.p., n.d. Web.
    <http://www.dur.ac.uk/martin.schroeder/Research%20Summary.htm>.
   "The Critical Roles of Endoplasmic Reticulum Chaperones and Unfolded Protein Response in Tumorigenesis and
    Anticancer Therapies." Nature.com. Nature Publishing Group, n.d. Web. 26 Sept. 2012.
    <http://www.nature.com/onc/journal/vaop/ncurrent/fig_tab/onc2012130f1.html>.

Mais conteúdo relacionado

Mais procurados

Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Katie K. Hsiao
 
antiapoptotic effect of Ach (research paper by Marta sloniecka)
antiapoptotic effect of Ach (research paper by Marta sloniecka)antiapoptotic effect of Ach (research paper by Marta sloniecka)
antiapoptotic effect of Ach (research paper by Marta sloniecka)Prajjwal Rajput
 
Participation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamateParticipation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamateankit
 
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)Jack Gengcheng YANG
 
Expression of N-terminal seven amino acids peptide of fibrin (β–peptide) on...
Expression of  N-terminal  seven amino acids peptide of fibrin (β–peptide) on...Expression of  N-terminal  seven amino acids peptide of fibrin (β–peptide) on...
Expression of N-terminal seven amino acids peptide of fibrin (β–peptide) on...Aref Farokhi Fard
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
 
Final poster 1
Final poster 1Final poster 1
Final poster 1AFor1991
 

Mais procurados (9)

publication 2
publication 2publication 2
publication 2
 
Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014Hsiao-DevNeurobiol2014
Hsiao-DevNeurobiol2014
 
antiapoptotic effect of Ach (research paper by Marta sloniecka)
antiapoptotic effect of Ach (research paper by Marta sloniecka)antiapoptotic effect of Ach (research paper by Marta sloniecka)
antiapoptotic effect of Ach (research paper by Marta sloniecka)
 
Participation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamateParticipation of the gabaergic system on the glutamate
Participation of the gabaergic system on the glutamate
 
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)
The invention of sprycel from benchtop to bedside (Gengcheng Jack Yang)
 
Expression of N-terminal seven amino acids peptide of fibrin (β–peptide) on...
Expression of  N-terminal  seven amino acids peptide of fibrin (β–peptide) on...Expression of  N-terminal  seven amino acids peptide of fibrin (β–peptide) on...
Expression of N-terminal seven amino acids peptide of fibrin (β–peptide) on...
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
Armstead, William
Armstead, WilliamArmstead, William
Armstead, William
 
Final poster 1
Final poster 1Final poster 1
Final poster 1
 

Semelhante a The Effects of GCSF on Stroke Induced Rats

J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)Hyunsun Park
 
Duchenne drug tested for muscular dystrophy as drug repurposing
Duchenne drug tested for muscular dystrophy as drug repurposingDuchenne drug tested for muscular dystrophy as drug repurposing
Duchenne drug tested for muscular dystrophy as drug repurposingmovvaharshavardhan
 
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...Sherman Jia
 
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...Golden Helix
 
Spilman tropisetron brain research
Spilman tropisetron brain researchSpilman tropisetron brain research
Spilman tropisetron brain researchpatricia spilman
 
Neurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxNeurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxRBalaraman4
 
Posterpresentation Psy410
Posterpresentation Psy410Posterpresentation Psy410
Posterpresentation Psy410lensingj
 
PIIS1552526009012771(1)(3)
PIIS1552526009012771(1)(3)PIIS1552526009012771(1)(3)
PIIS1552526009012771(1)(3)Marco Garza
 
Screening Of Mdr1 [Autosaved]
Screening Of  Mdr1 [Autosaved]Screening Of  Mdr1 [Autosaved]
Screening Of Mdr1 [Autosaved]Pooja1923
 
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...Ram Sahu
 
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives, PhD
 

Semelhante a The Effects of GCSF on Stroke Induced Rats (20)

J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)
 
Duchenne drug tested for muscular dystrophy as drug repurposing
Duchenne drug tested for muscular dystrophy as drug repurposingDuchenne drug tested for muscular dystrophy as drug repurposing
Duchenne drug tested for muscular dystrophy as drug repurposing
 
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
Genome sequencing uncovers MS phenocopies in primary progressive multiple scl...
 
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...
Yearly Clinical Review of a Patient’s WGS Results Leads to a New Gene Candida...
 
ACCP publication
ACCP publication ACCP publication
ACCP publication
 
Spilman tropisetron brain research
Spilman tropisetron brain researchSpilman tropisetron brain research
Spilman tropisetron brain research
 
Neurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxNeurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptx
 
Posterpresentation Psy410
Posterpresentation Psy410Posterpresentation Psy410
Posterpresentation Psy410
 
PIIS1552526009012771(1)(3)
PIIS1552526009012771(1)(3)PIIS1552526009012771(1)(3)
PIIS1552526009012771(1)(3)
 
article2
article2article2
article2
 
Screening Of Mdr1 [Autosaved]
Screening Of  Mdr1 [Autosaved]Screening Of  Mdr1 [Autosaved]
Screening Of Mdr1 [Autosaved]
 
958461
958461958461
958461
 
PNAS-2015-Messer
PNAS-2015-MesserPNAS-2015-Messer
PNAS-2015-Messer
 
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...
Effects of atorvastatin and streptozocin on immunohistochemical markers in hi...
 
HB poster - AES2
HB poster - AES2HB poster - AES2
HB poster - AES2
 
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
 
Genzyme Poster
Genzyme PosterGenzyme Poster
Genzyme Poster
 
11JNN-4922-NSM10
11JNN-4922-NSM1011JNN-4922-NSM10
11JNN-4922-NSM10
 
Case
CaseCase
Case
 
Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain InjuryEffect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury
 

The Effects of GCSF on Stroke Induced Rats

  • 1. THE EFFECTS OF GRANULOCYTE COLONY STIMULATING FACTOR ON STROKE INDUCED RATS Matthew Busel Pine Crest School Work conducted at Florida Atlantic University
  • 2. INTRODUCTION: GCSF  Granulocyte Colony Stimulating Factor (GCSF) is a growth factor and cytokine that stimulates the proliferation and mobilization of hematopoietic stem cells  Its actions are mediated by binding to specific GCSF receptors (GCSFRs)  Although its main clinical use has been to counteract neutropenia, recent studies have reported that GCSFRs are located on the brain leading to neuroprotective effects of the drug  By decreasing the rate of neuronal death many central nervous system (CNS) disorders may be counteracted against
  • 3. INTRODUCTION: CEREBRAL ISCHEMIA  Focal cerebral ischemia (stroke) is a CNS disorder in which the cerebral blood vessels are blocked, resulting in an inadequate blood flow to the brain and subsequent oxygen (hypoxic) – glucose deprived environment  In this state the brain cannot meet metabolic demands and neuronal death will eventually be initiated via apoptosis  The resulting ischemic infarct (area of dead cell tissue) includes a central core (an area of severe ischemia) and a surrounding penumbra, which is vulnerable if the cell death is not arrested White = core Red = penumbra
  • 4. INTRODUCTION: APOPTOTIC PATHWAYS  The endoplasmic reticulum (ER) is responsible for the proper folding and sorting of proteins  During an ischemic insult the ER becomes stressed and will try to restore normal function by deactivating protein translation signaling pathways while activating other pathways that increase the production of chaperone molecules that facilitates protein folding  If it is unsuccessful in rectifying its stressed state and restoring normal function, the ER will initiate an apoptotic cascade  Caspase 12 is an ER-membrane associated protein and one of the initiators of the caspase-mediated apoptotic pathway  Glucose regulated protein 78 (GRP78) is a chaperon molecule associated with the ER
  • 5. INTRODUCTION: EXPERIMENT  The molecular expression of GRP78 and Caspase 12 were compared in GCSF treated and untreated rats  Both GRP78 and Caspase 12 are excellent indicators of cell death
  • 6. HYPOTHESIS  If the molecular expression of GRP78 and Caspase 12 are measured in GCSF treated and untreated rats after focal cerebral ischemia, treated rats will have lower expression of the selected indicators and therefore lower cell death in both the core and penumbra of the brain
  • 7. METHODS: WESTERN BLOT  Frozen homogenates/lysates of protein samples (from two rats to increase diversity with sample population) were used to perform western blot assays  Briefly, protein homogenates/lysates were boiled for 5 minutes and centrifuged  Each lane was loaded with 50 μg of protein and subjected to sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) on 12% gels and then electrophoretically transferred to nitrocellulose membranes  Once protein transfers were completed, the nitrocellulose membranes were blocked in 5% nonfat dry milk in TBST (20 mmol/L Tris base, pH 7.6, 137 mmol/L NaCl, and 0.05% Tween 20) for 1 hour at room temperature and rinsed in TBS-T (50 mM Tris, 170 mM NaCl, 0.2% [vol/vol] Tween 20; pH 7.5)
  • 8. METHODS: WESTERN BLOT  They were then incubated with primary antibodies (anti-caspase 12, anti-Grp78 and anti-GAPDH, all at 1:1000 dilution) and incubated in TBST and the corresponding primary antibody (1:1000) overnight at 4°C  The membranes were subsequently washed in TBST and incubated for 1.5 hours at room temperature with the same corresponding secondary antibody in a dilution of 1:3000 with TBST  Immunoreactive bands were visualized in the linear range with enhanced chemoluminescence  Films were scanned and the optical density was determined with ImageJ
  • 9. METHODS: ANALYSIS  All statistical data shown was expressed as the mean optical density for each treatment  A one-way ANOVA test was used to compare means between groups and determine statistical significance  Differences of P<0.05 were considered statistically significant
  • 10. RESULTS: CASPASE 12  This figure shows the mean normalized optical density values determined by ImageJ for Caspase 12  GAPDH was used as the internal control to normalize values Click to next slide for more explanation Legend (50 mg protein lysate in each well) 1. Naïve- non-operated controls 2. Sham- operated controls not given focal ischemia 3. MCAO- rats were given focal ischemia by middle cerebral artery occlusion 4. MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
  • 11. RESULTS: CASPASE 12  The data demonstrates a relatively large decrease in expression between the MCAO and MCAO+GCSF groups in the core and an increase between groups in the penumbra Caspase 12: 40 kDa 1 2 3 4 Legend (50 mg protein lysate in each well) 1. Naïve- non-operated controls 2. Sham- operated controls not given focal ischemia 3. MCAO- rats were given focal ischemia by middle cerebral artery occlusion 4. MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
  • 12. RESULTS: CASPASE 12  ANOVA Tests were run for the results of both the core and penumbra  Since both had p values > .05, results were determined to be statistically insignificant Core Penumbra
  • 13. RESULTS: CASPASE 12  A T-Test was then run which also proved results to be statistically insignificant because the p value > .05
  • 14. RESULTS: GRP78  This figure displays the mean normalized optical density values determined by ImageJ for GRP78  GAPDH was used as the internal control to normalize values Click to next slide for more explanation Legend (50 mg protein lysate in each well) 1. Naïve- non-operated controls 2. Sham- operated controls not given focal ischemia 3. MCAO- rats were given focal ischemia by middle cerebral artery occlusion 4. MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
  • 15. RESULTS: GRP78  The data demonstrates a decrease in expression between the MCAO and MCAO+GCSF groups in the core and an increase in the penumbra GRP78: 72-80 kDa 1 2 3 4 Legend (50 mg protein lysate in each well) 1. Naïve- non-operated controls 2. Sham- operated controls not given focal ischemia 3. MCAO- rats were given focal ischemia by middle cerebral artery occlusion 4. MCAO+GCSF- rats were given focal ischemia by middle cerebral artery occlusion and administered GCSF
  • 16. RESULTS: SUMMARY  With both Caspase 12 and GRP78, there was a decrease in expression in the treated rats in the core, but an increase in expression in the treated rats in the penumbra
  • 17. DISCUSSION: CASPASE 12 RESULTS  In response to excess calcium in the ER lumen, an apoptotic cascade is initiated involving Caspase 12 with the final death marker prior to apoptosis being Caspase 3  Consistent with previous studies, the core GCSF-treated rats showed reduced Caspase 12 expression  The penumbra GCSF-treated rats showed increased Caspase 12 expression in the penumbra in complete disagreement with previous studies
  • 18. DISCUSSION: GRP78 RESULTS  In the absence of ER stress, the chaperone protein GRP78 protects cells from apoptosis by binding to IRE1, PERK, ATF6, and Caspase 14  GRP78 normally inhibits the activation of these intracellular cytoplasmic kinases but when the ER is stressed, GRP78 dissociates from the cytoplasmic molecules to sequester the extra calcium  Similar to the results with Caspase 12, the core-GCSF treated groups decreased GRP78 expression, but in the penumbra the opposite effect occurred.
  • 19. DISCUSSION: STATISTICS  There was no statistical significance between any of the treatment groups analyzed  A possible reason for this result is the relatively small sample size of data used in this experiment compared to similar studies  Also there was a relatively high level of variation within each group, which may have contributed to some of the observed discrepancies in the data analysis  Another statistical discrepancy may have come from GAPDH, which was used to normalize OD values  As demonstrated in Figure 1, the expression of GAPDH in the MCAO group was significantly smaller than any other group making the normalized value of the MCAO group relatively smaller
  • 20. FUTURE RESEARCH  In future research, additional Western Blots with Caspase 12 and GRP78 would be run in order to compile more data and create more reliable results  As this research only investigated pro-death markers (Caspase 12) and ER stress indicators (GRP78), it would be interesting to assay BCl2, a pro-survival marker in future research
  • 21. SOURCES  Http://www.weizmann.ac.il/immunology/Lapidot/documents/5.pdf (2002): n. pag. 17 June 2002. Web.  "Annals of Oncology." G-CSF Prevents the Suppression of Bone Marrow Hematopoiesis Induced by IL-12 and Augments Its Antitumor Activity in a Melanoma Model in Mice. N.p., n.d. Web. 26 Sept. 2012. <http://annonc.oxfordjournals.org/content/9/1/63.short>.  "Phenotypic Changes in Neutrophil Granulocytes after G-CSF Administration in Patients with Acute Lymphoblastic Leukemia under Chemotherapy." Phenotypic Changes in Neutrophil Granulocytes after G-CSF Administration in Patients with Acute Lymphoblastic Leukemia under Chemotherapy. N.p., n.d. Web. 26 Sept. 2012. <http://www.haematologica.org/content/83/6/573.abstract>.  "A Role for G-CSF ( Granulocyte-Colony Stimulating Factor ) Review ND ABBREVIATIONS SC." Free Reference Manager and PDF Organizer. N.p., n.d. Web. 26 Sept. 2012. <http://www.mendeley.com/research/a-role-for-gcsf-granulocytecolony-stimulating-factor- review-nd-abbreviations-sc/>.  Khan, Shaheen N., and Fridoon J. Ahmad. "IGF-1 and G-CSF Complement Each Other in BMSC Migration towards Infarcted Myocardium in a Novel in Vitro Model." Cell Biology International 33.6 (2009): n. pag. June 2009. Web. <IGF-1 and G-CSF complement each other in BMSC migration towards infarcted myocardium in a novel in vitro model>.  Chopp, M., S. Frinak, D. R. Walton, and M. B. Smith. "Intracellular Acidosis during and after Cerebral Ischemia: In Vivo Nuclear Magnetic Resonance Study of Hyperglycemia in Cats." N.p., n.d. Web. <http://stroke.ahajournals.org/content/18/5/919.full.pdf>.
  • 22. SOURCES  “Neuroprotective Effect of Recombinant Human Granulocyte Colony-stimulating Factor in Transient Focal Ischemia of Mice." Nature.com. Nature Publishing Group, n.d. Web. 26 Sept. 2012.  "Anti-apoptotic Effect of Granulocyte-colony Stimulating Factor after Focal Cerebral Ischemia in the Rat." Neuroscience 143.4 (2006): 965-74. 28 Dec. 2006. Web. <http://www.sciencedirect.com/science/article/pii/S0306452206012310>.  Pan, Chunliu, Amit Gupta, Howard Prentice, and Jang-yen Wu. "Protection of Taurine and Granulocyte Colony- Stimulating Factor against Excitotoxicity Induced by Glutamate in Primary Cortical Neurons." N.p., 2010. Web. <http://www.biomedcentral.com/content/pdf/1423-0127-17-S1-S18.pdf>.  "Neuroprotective Effect of Granulocyte Colonyâ Stimulating Factor After Focal Cerebral Ischemia." Neuroprotective Effect of Granulocyte Colonyâ Stimulating Factor After Focal Cerebral Ischemia. N.p., n.d. Web. 26 Sept. 2012. <http://stroke.ahajournals.org/content/34/3/745.long>.  "Anti-apoptotic Effect of Granulocyte-colony Stimulating Factor after Focal Cerebral Ischemia in the Rat." Neuroscience 143.4 (2006): 965-74. 28 Dec. 2006. Web. <http://www.sciencedirect.com/science/article/pii/S0306452206012310>.  "Caspase-12 Mediates Endoplasmic-reticulum-specific Apoptosis and Cytotoxicity by Amyloid-beta." National Center for Biotechnology Information. U.S. National Library of Medicine, n.d. Web. 26 Sept. 2012. <http://www.ncbi.nlm.nih.gov/pubmed/10638761>.  "Research." School of Biological and Biomedical Sciences Interorganellar Signalling Laboratory. N.p., n.d. Web. <http://www.dur.ac.uk/martin.schroeder/Research%20Summary.htm>.  "The Critical Roles of Endoplasmic Reticulum Chaperones and Unfolded Protein Response in Tumorigenesis and Anticancer Therapies." Nature.com. Nature Publishing Group, n.d. Web. 26 Sept. 2012. <http://www.nature.com/onc/journal/vaop/ncurrent/fig_tab/onc2012130f1.html>.